Clinical Trials Directory

Trials / Completed

CompletedNCT02907554

Cyclosporine a Pretreatment and Kidney Graft Function

Effects of Cyclosporine a Pretreatment of Deceased Donor on Kidney Graft Function: a Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
648 (actual)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Organ donors included in the study are randomized to a control group or an intervention group receiving 2.5 mg/kg of cyclosporine A before organ procurement. Harvested kidneys from these patients are transplanted to chronic kidney insufficiency patients. According to the pretreatment of the transplant, delayed graft function during the first week was evaluated as well as kidney function at different timepoints and mortality during the first year after transplantation.

Detailed description

Organ donors included in the study are randomized to a control group receiving a placebo or an intervention group receiving 2.5 mg/kg of cyclosporine A before organ procurement. In the operating theater organs are harvested. Thereafter, harvested kidneys from these patients are transplanted to chronic kidney insufficiency patients. The management of transplanted patients is performed as usual. According to the pretreatment of the transplant, delayed graft function during the first week (need of at least one dialysis session) was evaluated as well as kidney function at different timepoints (slow graft function, estimated creatinine clearance on day 3 and 7, acute and chronic graft rejection), length of hospital stay and mortality during the first year after transplantation.

Conditions

Interventions

TypeNameDescription
DRUGcyclosporine Athe intervention group receives 2.5 mg/kg of cyclosporine
DRUGPlacebocontrol group receives a placebo

Timeline

Start date
2017-12-19
Primary completion
2022-04-10
Completion
2023-04-03
First posted
2016-09-20
Last updated
2024-12-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02907554. Inclusion in this directory is not an endorsement.